Ganuza Miguel, McKinney-Freeman Shannon
Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Curr Opin Hematol. 2017 Jul;24(4):314-321. doi: 10.1097/MOH.0000000000000347.
Hematopoietic stem cells (HSCs) and progenitors are tasked with maintaining hematopoietic homeostasis in the face of numerous insults and challenges, including infection, inflammation, and exsanguination. HSCs possess the remarkable ability to reconstitute the entire hematopoietic system of an organism whose own hematopoietic system has been ablated. This ability is exploited routinely in the clinic via HSC transplantation (HSCT). Here, we focus on the physiological and molecular bottlenecks overcome by HSCs during transplantation.
During transplantation, HSCs encounter a damaged bone marrow niche, characterized molecularly by increases in oxygen concentrations and an altered cytokine milieu. New mechanisms and pathways have been recently implicated during HSCT, including transplanted HSC-dependent secretion of conditioning molecules that facilitate engraftment and pathways that protect HSCs from perturbed organelle homeostasis.
Better understanding the molecular processes HSCs employ to withstand the stress of transplant will illuminate novel targets for further improving conditioning regimens and engraftment during HSCT.
造血干细胞(HSC)和祖细胞的任务是在面对包括感染、炎症和失血在内的众多损伤和挑战时维持造血稳态。造血干细胞具有重建自身造血系统已被消融的生物体的整个造血系统的非凡能力。这种能力在临床上通过造血干细胞移植(HSCT)被常规利用。在此,我们关注造血干细胞在移植过程中克服的生理和分子瓶颈。
在移植过程中,造血干细胞会遇到受损的骨髓微环境,其分子特征是氧浓度增加和细胞因子环境改变。最近在造血干细胞移植过程中涉及了新的机制和途径,包括移植的造血干细胞依赖的调节分子分泌,这些分子促进植入,以及保护造血干细胞免受细胞器稳态紊乱影响的途径。
更好地理解造血干细胞用于承受移植应激的分子过程将为进一步改善造血干细胞移植期间的预处理方案和植入提供新的靶点。